The fallacy of single-agent chemotherapy for cancer.
Henry S
HS
Friedman
Jill
J
Maxwell
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005909:Glioblastoma / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D006801:Humans; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000032:analysis / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D012680:Sensitivity and Specificity; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D014408:Biomarkers, Tumor; D003606:Dacarbazine; D019853:O(6)-Methylguanine-DNA Methyltransferase; D000077204:Temozolomide